Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

News in Brief

Nobel Recognizes Seminal Work in DNA Repair

DOI: 10.1158/2159-8290.CD-NB2015-151 Published December 2015
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Three scientists—Thomas Lindahl, PhD, Paul Modrich, PhD, and Aziz Sancar, MD, PhD—will share this year's Nobel Prize in Chemistry for pioneering research that established the inherent instability of DNA and the cellular mechanisms underlying its repair. Their work was critical to the development of conventional DNA-damaging cancer treatments and laid the foundation for newer therapies that inhibit repair pathways.

“Understanding these pathways provides us with the tools for identifying new anticancer drugs that can inhibit these repair mechanisms, and sensitize cancers to conventional chemotherapy and radiation,” says Alan D—Andrea, MD, director of the Center for DNA Damage and Repair at Harvard Medical School in Boston, MA. “That's helped in developing small-molecule inhibitors that interfere with cancer cells' ability to repair DNA damage and render them more sensitive to certain kinds of chemotherapy.”

As a case in point, the FDA last year approved olaparib (Lynparza; AstraZeneca), a PARP inhibitor that blocks the enzymes involved in base excision repair (BER), the pathway described by Lindahl. The drug was approved to treat advanced ovarian cancer associated with BRCA mutations.

BER is a process in which an altered base is removed by DNA glycosylases, followed by excision of the resulting sugar phosphate. The gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase. Lindahl, of the Francis Crick Institute and Clare Hall Laboratory in Hertfordshire, UK, identified a new family of DNA glycosylases and described their role in orchestrating BER.

Modrich, of the Howard Hughes Medical Institute and Duke University in Durham, NC, described mismatch repair, which corrects errors in DNA replication during cell division. Mismatches occur when an incorrect nucleotide is introduced during synthesis of a new DNA strand, resulting in formation of a non–Watson-Crick base pair that distorts the DNA. Defects in the mismatch repair genetic pathway have been found to cause hereditary nonpolyposis colon cancer.

Sancar, at the University of North Carolina, Chapel Hill, identified the enzymes involved in nucleotide excision repair (NER), which repairs DNA regions that contain chemical adducts, such as UV-induced thymine dimers that distort the DNA helix and interfere with replication and transcription. Mutations in the NER pathway are linked to a number of human genetic disorders, including xeroderma pigmentosum, characterized by hypersensitivity to UV radiation and a high risk for skin cancer.

Figure1

Tomas Lindahl

Figure2

Paul Modrich

Figure3

Aziz Sancar

“These repair systems are very specialized and recognize particular types of damage,” says Stephen Elledge, PhD, a researcher in the Department of Genetics at Harvard Medical School in Boston, MA, who studies DNA damage repair. “You can draw an analogy with fixing potholes in roads: BER and NER find the problem, clear it out, and fill it in for repair, while mismatch repair acts as an editor that follows behind the polymerase to double-check its work and make sure it's right.”

Notes

For more news on cancer research, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.

  • ©2015 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 5 (12)
December 2015
Volume 5, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Nobel Recognizes Seminal Work in DNA Repair
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Nobel Recognizes Seminal Work in DNA Repair
Cancer Discov December 1 2015 (5) (12) 1230-1231; DOI: 10.1158/2159-8290.CD-NB2015-151

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nobel Recognizes Seminal Work in DNA Repair
Cancer Discov December 1 2015 (5) (12) 1230-1231; DOI: 10.1158/2159-8290.CD-NB2015-151
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • COVID-19 Prolonged in Patients with Cancer
  • By The Numbers: Novel Drugs Approved by the FDA, 2011-2020
  • CAR Ts and BiTEs Shine in Multiple Myeloma
Show more News in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement